(Q43686202)

English

Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension (English)

1 reference

Europe PubMed Central

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

Larsson LI

1

1 reference

Europe PubMed Central

25 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

108

1 reference

Europe PubMed Central

25 November 2017

8

1 reference

Europe PubMed Central

25 November 2017

1439-1444

1 reference

Europe PubMed Central

25 November 2017

24-hour (nyctohemeral) and sleep-related variations of intraocular pressure in healthy white individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of the diurnal tension variations in normal and glaucomatous eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-four hourly variations in the inflow of the aqueous humour

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of withdrawal of timolol in chronically treated glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aqueous flow in open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Circadian intraocular pressure variation with beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 24 hour control with Timoptic 0.5% and Timoptic-XE 0.5% in exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual variability in the diurnal intraocular pressure curve

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diurnal variation of intraocular pressure and the overriding effects of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(01)00605-4

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43686202&oldid=2102505186"